Health Canada
- Status: approved
Additional ocular hypotensive medication (Additional ocular hypotensive medication) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Robin, Alan L., M.D. is the originator. The local marketing authorisation holder may differ — check the official source linked above.